Fiduciary Alliance LLC Makes New $262,000 Investment in Albemarle Co. (NYSE:ALB)

Fiduciary Alliance LLC acquired a new stake in Albemarle Co. (NYSE:ALBFree Report) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund acquired 3,040 shares of the specialty chemicals company’s stock, valued at approximately $262,000.

Several other large investors have also added to or reduced their stakes in the business. Primecap Management Co. CA boosted its holdings in shares of Albemarle by 0.5% during the 3rd quarter. Primecap Management Co. CA now owns 3,833,984 shares of the specialty chemicals company’s stock worth $363,117,000 after buying an additional 20,930 shares in the last quarter. Geode Capital Management LLC lifted its position in shares of Albemarle by 0.5% during the 3rd quarter. Geode Capital Management LLC now owns 2,741,906 shares of the specialty chemicals company’s stock valued at $258,797,000 after acquiring an additional 14,874 shares during the period. ProShare Advisors LLC boosted its stake in Albemarle by 10.2% during the second quarter. ProShare Advisors LLC now owns 1,568,602 shares of the specialty chemicals company’s stock worth $149,833,000 after acquiring an additional 144,705 shares in the last quarter. Dimensional Fund Advisors LP grew its holdings in Albemarle by 2.3% in the second quarter. Dimensional Fund Advisors LP now owns 1,311,331 shares of the specialty chemicals company’s stock worth $125,264,000 after purchasing an additional 29,721 shares during the period. Finally, Earnest Partners LLC increased its stake in Albemarle by 11.9% in the second quarter. Earnest Partners LLC now owns 1,198,730 shares of the specialty chemicals company’s stock valued at $114,503,000 after purchasing an additional 127,615 shares in the last quarter. Institutional investors and hedge funds own 92.87% of the company’s stock.

Insider Activity at Albemarle

In other Albemarle news, CEO J Kent Masters sold 2,525 shares of the business’s stock in a transaction dated Thursday, December 5th. The shares were sold at an average price of $101.12, for a total value of $255,328.00. Following the transaction, the chief executive officer now directly owns 73,747 shares in the company, valued at $7,457,296.64. The trade was a 3.31 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 0.38% of the stock is owned by company insiders.

Albemarle Stock Performance

Shares of Albemarle stock opened at $92.71 on Wednesday. The firm has a market capitalization of $10.90 billion, a P/E ratio of -5.53 and a beta of 1.58. The company has a current ratio of 2.44, a quick ratio of 1.58 and a debt-to-equity ratio of 0.43. The business’s fifty day simple moving average is $98.55 and its 200 day simple moving average is $93.89. Albemarle Co. has a 12 month low of $71.97 and a 12 month high of $143.19.

Albemarle Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Thursday, January 2nd. Investors of record on Friday, December 13th were issued a $0.405 dividend. This represents a $1.62 dividend on an annualized basis and a dividend yield of 1.75%. The ex-dividend date of this dividend was Friday, December 13th. Albemarle’s dividend payout ratio (DPR) is currently -9.67%.

Analyst Upgrades and Downgrades

ALB has been the subject of several research reports. KeyCorp reduced their target price on Albemarle from $132.00 to $127.00 and set an “overweight” rating for the company in a research note on Tuesday, November 12th. Robert W. Baird raised their price objective on Albemarle from $79.00 to $103.00 and gave the company a “neutral” rating in a research note on Wednesday, December 18th. Clarkson Capital began coverage on Albemarle in a research report on Tuesday. They set a “buy” rating and a $112.00 target price on the stock. Mizuho cut their target price on Albemarle from $110.00 to $105.00 and set a “neutral” rating on the stock in a report on Tuesday, January 7th. Finally, Oppenheimer decreased their price target on shares of Albemarle from $171.00 to $170.00 and set an “outperform” rating for the company in a research note on Friday, November 8th. One investment analyst has rated the stock with a sell rating, fifteen have issued a hold rating and seven have issued a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $115.65.

Read Our Latest Stock Analysis on Albemarle

Albemarle Profile

(Free Report)

Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Energy Storage, Specialties and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services.

Featured Articles

Want to see what other hedge funds are holding ALB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Albemarle Co. (NYSE:ALBFree Report).

Institutional Ownership by Quarter for Albemarle (NYSE:ALB)

Receive News & Ratings for Albemarle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle and related companies with MarketBeat.com's FREE daily email newsletter.